Depakote Sprinkles and Permapen Isoject

• Generic Name: divalproex sodium
• Dosage Forms: capsule, sprinkles
• Other Brand Names: Depakote ER, Depakote Sprinkles, Depakene, Depacon, Depakote

Depakote Sprinkles affects chemicals in the body that may be involved in causing seizures.

Depakote Sprinkles is used to treat various types of seizure disorders. This medicine is sometimes used together with other seizure medications.

Depakote Sprinkles is also used to treat manic episodes related to bipolar disorder (manic depression), and to prevent migraine headaches.

Depakote Sprinkles may also be used for purposes not listed in this medication guide.

• Generic Name: penicillin g benzathine
• Dosage Forms: Injectable Suspension 1,200,000 units
• Other Brand Names: Bicillin L-A

Oxycodone and acetaminophen combination is used to relieve pain severe enough to require opioid treatment and when other pain medicines did not work well enough or cannot be tolerated.

Acetaminophen is used to relieve pain and reduce fever in patients. It does not become habit-forming when taken for a long time. But acetaminophen may cause other unwanted effects when taken in large doses, including liver damage.

Oxycodone belongs to the group of medicines called narcotic analgesics (pain medicines). It acts on the central nervous system (CNS) to relieve pain.

When oxycodone is used for a long time, it may become habit-forming, causing mental or physical dependence. However, people who have continuing pain should not let the fear of dependence keep them from using narcotics to relieve their pain. Mental dependence (addiction) is not likely to occur when narcotics are used for this purpose. Physical dependence may lead to withdrawal side effects if treatment is stopped suddenly. However, severe withdrawal side effects can usually be prevented by gradually reducing the dose over a period of time before treatment is stopped completely.

This medicine is available only with your doctor's prescription. Percocet® and Xartemis™ are available only under a restricted distribution program called the Opioid Analgesic REMS (Risk Evaluation and Mitigation Strategy) program.